ABUS icon

Arbutus Biopharma
ABUS

Overview Fund Activity

51 hedge funds and large institutions have $47.6M invested in Arbutus Biopharma in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.

Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
12
Increased
14
Reduced
11
Closed
9
Calls
$1.21M
Puts
$5K
Net Calls
+$1.2M
Net Calls Change
+$467K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$6.1M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.32M
3
Squarepoint
3
Squarepoint
New York
$586K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$569K
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$1.77M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$2.46M
2
Millennium Management
2
Millennium Management
New York
$405K
3
HP
3
Hound Partners
New York
$0
4
Goldman Sachs
4
Goldman Sachs
New York
$3.03M
5
ACP
5
Acuta Capital Partners
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– -$172K -169,908 Closed
SIM
52
Spark Investment Management
New York
– -$28K -28,026 Closed
HF
53
HRT Financial
New York
– -$11K -11,700 Closed
State Street
54
State Street
Massachusetts
– -$12K -11,686 Closed
Group One Trading
55
Group One Trading
Illinois
– -$6K -5,476 Closed
1 2
3